Donate Now
Research Grants - 2009


Alzheimer's Assocation Research only
All of alz.org
  • Go to Alz.org
  • Research Center
  • AAIC
  • ISTAART
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Home
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Grants 2009


To view an abstract, select an author from the vertical list on the left.

2009 Grants - Guo

EPR Studies of the Early Events in Abeta Aggregation

Zhefeng Guo, Ph.D.
University of California, Los Angeles
Los Angeles, California

2009 New Investigator Research Grant

Beta-amyloid (also known as Abeta) is a protein fragment that aggregates into amyloid plaque, a characteristic feature of Alzheimer pathology. Before forming plaques, however, small numbers of beta-amyloid molecules can aggregate into clusters known as oligomers, which are toxic to nerve cells. Beta-amyloid oligomers have become an important focus of research because they may be an important target for drug development. However, very little is known about the structure of beta-amyloid oligomers or the conditions under which they form.

Zhefeng Guo, Ph.D. and colleagues plan to study the structure of beta-amyloid during the formation of oligomers. They are able to put labels on specific parts of the molecule that can be detected using a technique called electron paramagnetic resonance (EPR). Using EPR the researchers are able to determine the structure of beta-amyloid and which parts of the molecule participate in the formation of oligomers. The researchers will also study the size and structure of fully formed oligomers, as well as the distance between individual beta-amyloid molecules. The results of these studies will allow

Dr. Guo's team to build molecular models of beta-amyloid oligomers, which may be used to design drugs that block their formation.